CompanyALXONasdaqSouth San Francisco, CA

ALX Oncology Inc.

ALX Oncology develops cancer immunotherapies.

SEC EDGAR ClinicalTrials.gov alxoncology.com

SCHEDULE 13G/AAug 14Latest SEC filing

Aug 6Latest story

August 2026

ALX Oncology posts Q2 2026 results, reaffirms mid-2027 ASPEN-09-Breast readout

Aug 6Quarterly updateALX Oncology Inc.

June 2026

ALX Oncology names Scott Garland chairman, hires Michael Listgarten as general counsel

Jun 30PeopleALX Oncology Inc.